Luke Schenck

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Intellectual Disability

Room Temperature

Top Venues

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-Sheng Liu, Joseph Della Rocca, Luke Schenck, Athanas Koynov, Renee J Sifri, Matthew S Winston, Derek S Frank
Poly(vinylpyridine- co -vinylpyridine N -oxide) Excipients Mediate Rapid Dissolution and Sustained Supersaturation of Posaconazole Amorphous Solid Dispersions. Molecular pharmaceutics (2024)
Yu-Sheng Liu, Joseph Della Rocca, Luke Schenck, Athanas Koynov, Renee J Sifri, Matthew S Winston, Derek S Frank
Poly(vinylpyridine- co -vinylpyridine N -oxide) Excipients Mediate Rapid Dissolution and Sustained Supersaturation of Posaconazole Amorphous Solid Dispersions. Molecular pharmaceutics 21 (3) (2024)
Yu-Sheng Liu, Joseph Della Rocca, Luke Schenck, Athanas Koynov, Renee J Sifri, Matthew S Winston, Derek S Frank
Poly(vinylpyridine- co -vinylpyridine N -oxide) Excipients Mediate Rapid Dissolution and Sustained Supersaturation of Posaconazole Amorphous Solid Dispersions. Molecular pharmaceutics 21 (3) (2024)
Kristen N Kelsall, Leila M Foroughi, Derek S Frank, Luke Schenck, Anthony LaBuda, Adam J Matzger
Structural Modifications of Polyethylenimine to Control Drug Loading and Release Characteristics of Amorphous Solid Dispersions. Molecular pharmaceutics (2023)
Kristen N Kelsall, Leila M Foroughi, Derek S Frank, Luke Schenck, Anthony LaBuda, Adam J Matzger
Structural Modifications of Polyethylenimine to Control Drug Loading and Release Characteristics of Amorphous Solid Dispersions. Molecular pharmaceutics 20 (3) (2023)
Kristen N Kelsall, Leila M Foroughi, Derek S Frank, Luke Schenck, Anthony LaBuda, Adam J Matzger
Structural Modifications of Polyethylenimine to Control Drug Loading and Release Characteristics of Amorphous Solid Dispersions. Molecular pharmaceutics 20 (3) (2023)
Kristen N Kelsall, Leila M Foroughi, Derek S Frank, Luke Schenck, Anthony LaBuda, Adam J Matzger
Structural Modifications of Polyethylenimine to Control Drug Loading and Release Characteristics of Amorphous Solid Dispersions. Molecular pharmaceutics 20 (3) (2023)
Zijian Wang, Marina Solomos, Stephanus Axnanda, Chienhung Chen, Margaret Figus, Luke Schenck, Changquan Calvin Sun
Varied Bulk Powder Properties of Micro-Sized API within Size Specifications as a Result of Particle Engineering Methods. Pharmaceutics 14 (9) (2022)
Derek S Frank, Prateek Prasad, Luca Iuzzolino, Luke Schenck
Dissolution Behavior of Weakly Basic Pharmaceuticals from Amorphous Dispersions Stabilized by a Poly(dimethylaminoethyl Methacrylate) Copolymer. Molecular pharmaceutics 19 (9) (2022)
Luke Schenck, Christopher Boyce, Derek Frank, Sampada Koranne, Heidi M Ferguson, Neil Strotman
Hierarchical Particle Approach for Co-Precipitated Amorphous Solid Dispersions for Use in Preclinical In Vivo Studies. Pharmaceutics 13 (7) (2021)
Luke Schenck, Deniz Erdemir, Lindsey Saunders Gorka, Jeremy M Merritt, Ivan Marziano, Raimundo Ho, Mei Lee, Joseph Bullard, Moussa Boukerche, Steven Ferguson, Alastair J Florence, Saif A Khan, Changquan Calvin Sun
Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies. Molecular pharmaceutics 17 (7) (2020)